Robert Shafer
Robert Shafer
Professor of Medicine, Stanford University
Email verificata su stanford.edu - Home page
TitoloCitata daAnno
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
8422009
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
TIHIVC Study
Science (New York, NY) 330 (6010), 1551, 2010
7532010
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee, MJ Gonzales, R Kantor, BJ Betts, J Ravela, RW Shafer
Nucleic acids research 31 (1), 298-303, 2003
7242003
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
PM Small, RW Shafer, PC Hopewell, SP Singh, MJ Murphy, E Desmond, ...
New England Journal of Medicine 328 (16), 1137-1144, 1993
6841993
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Gnthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2011
6252011
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
RW Shafer, LM Smeaton, GK Robbins, SW De Gruttola, Victor, Snyder, ...
New England Journal of Medicine 349 (24), 2304-15, 2003
548*2003
2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Gnthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 24 (4), 132, 2016
5352016
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance
C Wang, Y Mitsuya, B Gharizadeh, M Ronaghi, RW Shafer
Genome research 17 (8), 1195-1201, 2007
4592007
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu, RW Shafer
Clinical infectious diseases 42 (11), 1608-1618, 2006
4472006
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART
RW Shafer, JM Schapiro
AIDS reviews 10 (2), 67, 2008
3862008
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection.
RW Shafer, DS Kim, JP Weiss, JM Quale
Medicine 70 (6), 384-397, 1991
3811991
Genotypic testing for human immunodeficiency virus type 1 drug resistance
RW Shafer
Clinical microbiology reviews 15 (2), 247-277, 2002
3752002
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ...
AIDS (London, England) 21 (2), 215, 2007
3582007
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS medicine 2 (4), e112, 2005
3552005
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
AK Iversen, RW Shafer, K Wehrly, MA Winters, JI Mullins, B Chesebro, ...
Journal of Virology 70 (2), 1086-1090, 1996
2931996
HIV-1 antiretroviral resistance
MW Tang, RW Shafer
Drugs 72 (9), e1-e25, 2012
2922012
Update of the drug resistance mutations in HIV-1: March 2013
VA Johnson, V Calvez, HF Gnthard, R Paredes, D Pillay, RW Shafer, ...
Topics in antiviral medicine 21 (1), 6, 2013
2862013
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
DW Haas, LM Smeaton, RW Shafer, GK Robbins, GD Morse, L Labb, ...
The Journal of infectious diseases 192 (11), 1931-1942, 2005
2772005
Rationale and uses of a public HIV drug‐resistance database
RW Shafer
The Journal of infectious diseases 194 (Supplement_1), S51-S58, 2006
2752006
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade
RW Shafer, BR Edlin
Clinical infectious diseases 22 (4), 683-704, 1996
2571996
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20